D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$327M |
| 2 |
Netflix
NFLX
|
+$275M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$219M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Merck
MRK
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$558M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$259M |
| 3 |
Meta Platforms (Facebook)
META
|
+$252M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$252M |
| 5 |
IBM
IBM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.41% |
| 2 | Technology | 6.9% |
| 3 | Consumer Discretionary | 6.89% |
| 4 | Communication Services | 6.41% |
| 5 | Healthcare | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
3751
Franklin Street Properties
FSP
$45.7M
| $459K | ﹤0.01% |
38,424
-128,574
| -77% | -$1.64M |
|
3752
NVE Corp
NVEC
$568M
| $459K | ﹤0.01% |
+7,868
| New | +$426K |
|
|
ELOS
3753
DELISTED
Syneron Medical Ltd
ELOS
| $459K | ﹤0.01% |
+37,311
| New | +$388K |
|
|
RVBD
3754
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $459K | ﹤0.01% |
25,366
-82,938
| -77% | -$1.34M |
|
3755
Kemper
KMPR
$1.73B
| $458K | ﹤0.01% |
11,200
-53,665
| -83% | -$2.04M |
|
|
BKW
3756
PUT
DELISTED
BURGER KING WORLDWIDE
BKW
| $457K | ﹤0.01% |
20,000
| – | – |
|
3757
CTS Corp
CTS
$1.73B
| $456K | ﹤0.01% |
+22,905
| New | +$409K |
|
3758
Teledyne Technologies
TDY
$30.2B
| $456K | ﹤0.01% |
4,969
-26,975
| -84% | -$2.4M |
|
|
ZLC
3759
PUT
DELISTED
ZALE CORPORATION
ZLC
| $456K | ﹤0.01% |
+28,900
| New | +$438K |
|
3760
CALL
Masco
MAS
$16.4B
| $455K | ﹤0.01% |
22,760
| – | – |
|
|
TTSH
3761
PUT
DELISTED
Tile Shop Holdings
TTSH
| $455K | ﹤0.01% |
25,200
| – | – |
|
3762
First Financial Bankshares
FFIN
$4.94B
| $453K | ﹤0.01% |
27,324
-55,092
| -67% | -$860K |
|
|
PRSS
3763
DELISTED
CafePress Inc.
PRSS
| $452K | ﹤0.01% |
71,335
+53,086
| +291% | +$324K |
|
|
NTLS
3764
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $452K | ﹤0.01% |
+22,363
| New | +$447K |
|
|
JNPR
3765
PUT
DELISTED
Juniper Networks
JNPR
| $451K | ﹤0.01% |
20,000
-5,100
| -20% | -$103K |
|
|
SGMO
3766
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $451K | ﹤0.01% |
32,479
+14,204
| +78% | +$164K |
|
|
NTUS
3767
CALL
DELISTED
Natus Medical Inc
NTUS
| $450K | ﹤0.01% |
+20,000
| New | +$386K |
|
|
SLXP
3768
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $450K | ﹤0.01% |
+5,000
| New | +$399K |
|
3769
CALL
Deluxe
DLX
$1.22B
| $449K | ﹤0.01% |
8,600
-22,600
| -72% | -$1.08M |
|
3770
Lee Enterprises
LEE
$173M
| $449K | ﹤0.01% |
12,942
+2,711
| +26% | +$88.7K |
|
3771
CALL
Arch Capital
ACGL
$36.3B
| $448K | ﹤0.01% |
22,500
-18,900
| -46% | -$363K |
|
3772
St. Joe Company
JOE
$3.56B
| $445K | ﹤0.01% |
23,210
-115,378
| -83% | -$2.14M |
|
3773
Alnylam Pharmaceuticals
ALNY
$37.2B
| $444K | ﹤0.01% |
6,900
+3,601
| +109% | +$215K |
|
3774
Pilgrim's Pride
PPC
$6.94B
| $444K | ﹤0.01% |
27,300
-80,652
| -75% | -$1.26M |
|
|
SURG
3775
DELISTED
SYNERGETICS USA, INC.
SURG
| $444K | ﹤0.01% |
122,555
+78,848
| +180% | +$322K |
|
Similar funds
D.E. Shaw & Co's Q4 2013 Portfolio in Review
As of Q4 2013, D.E. Shaw & Co held 4,972 positions worth $73.3B, up 17% from $62.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $3.59B of net new capital in Q4 2013, opening 721 new positions and adding to 1,786 existing holdings. Its largest new stake was Allegion: 2,233,249 shares worth $98.7M.
By sector, the portfolio is most concentrated in Financials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $252M trimmed.
- D.E. Shaw & Co's largest Q4 2013 buy was Allegion: 2,233,249 shares worth $98.7M.
- D.E. Shaw & Co added most to Bank of America in Q4 2013, an estimated $327M increase.
- D.E. Shaw & Co's biggest Q4 2013 reduction was Meta Platforms (Facebook), cutting an estimated $252M.
- D.E. Shaw & Co fully exited DELL INC in Q4 2013, selling an estimated $558M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $73.3B portfolio in Q4 2013.
- D.E. Shaw & Co opened 721 new positions and closed 549 in Q4 2013.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $73.3B.
Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.